Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.
Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 41 - 50 of 57 |
Cambridge, Massachusetts
Director, Biostatistics Summary of Key Responsibilities Leads large and/or complex late phase clinical development program. Represents Biostatistics and the broader Data Sciences and Statistics team including Data Management and Statistical...
15d
| Job Type | Full Time |
Senior Director, CMC Program Management
Cambridge, Massachusetts
This role is considered Hybrid. Overview This role will oversee the development and execution of the overall strategy for novel siRNA conjugate programs, which includes small molecules, peptides and protein ligands. Working closely with oth...
15d
| Job Type | Full Time |
Principal Clinical Data Manager
Cambridge, Massachusetts
This role is considered Virtual. The Principal Clinical Data Manager will lead and contribute to data management activities in support of Alnylam studies across all stages of clinical drug development. This position reports to the Director,...
15d
| Job Type | Full Time |
Cambridge, Massachusetts
This role is considered Hybrid. Overview The Executive Assistant will provide detailed administrative support to the SVP, Chief Accounting Officer (CAO), Vice President, Global Strategic Sourcing, Vice President, Internal Audit and Vice Pre...
16d
| Job Type | Full Time |
Cambridge, Massachusetts
This is a hybrid role based in Cambridge, MA. The selected candidate must commit to working on-site at least 2 days per week. Remote candidates will not be considered. The Principal Medical Writer represents medical writing on multi-discipl...
19d
| Job Type | Full Time |
Principal Statistical Programmer
Cambridge, Massachusetts
This role is considered Hybrid. Principal Statistical Programmer The Principal Statistical Programmer will provide expert-level hands-on principal programming support and technical leadership to develop, maintain, validate and run SAS compu...
20d
| Job Type | Full Time |
Senior Manager, Study Start Up
Cambridge, Massachusetts
This role is considered Hybrid. Overview Alnylam Pharmaceuticals is seeking a Senior Manager, Study Start-up to join our dynamic and growing team. The Senior Manager, Study Start-up partners closely with the Clinical Operations study team l...
20d
| Job Type | Full Time |
Director, New Product Commercialization
Cambridge, Massachusetts
Overview The Director New Product Commercialization, Zilebesiran is a pivotal role that will support all commercial activities related to the successful commercialization of Zilebesiran, Alnylam's flagship development program in hypertensio...
20d
| Job Type | Full Time |
Senior Scientist, Statistical Genetics
Cambridge, Massachusetts
Overview The Research Department at Alnylam is seeking a passionate and creative Senior Scientist to join the Alnylam Human Genetics (AHG) team and play a leading role in applying human genetics in drug discovery and development. AHG has ac...
20d
| Job Type | Full Time |
Cambridge, Massachusetts
Overview Alnylam Pharmaceuticals is seeking a dynamic and innovative Vice President of Data & AI to lead our data management, data quality, data engineering and artificial intelligence efforts. This executive role will be responsible for de...
20d
| Job Type | Full Time |